Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
The recent pullback in Simply Good Foods Co.’s (NASDAQ: SMPL) shares offers “an attractive entry point” into a company offering stable growth in a volatile market, according to Stephens.